Alzheimer’s drug Leqembi promises to give patients more time, but they face a long road to treatment

[ad_1] Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen…

GEHC gives reasons to look beyond temporary China woes and shares reverse higher

[ad_1] GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply…

Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know

[ad_1] The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on…

FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage

[ad_1] The Food and Drug Administration on Thursday fully approved the Alzheimer’s treatment Leqembi, a pivotal…

Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024

[ad_1] Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET…

Newseum Global